Novartis Pharma Gmbh v Apozyt Gmbh: ECJ 31 Jan 2013

ECJ Public health – Procedures for the authorisation of medicinal products for human use – Medicinal product with marketing authorisation specifying the container in which the product is to be placed on the market – Product transferred into another container – Whether a new marketing authorisation is required

Judges:

Sharpston AG

Citations:

C-535/11, [2013] EUECJ C-535/11

Links:

Bailii

European

Updated: 13 November 2022; Ref: scu.470793